MeV-Stealth: A CD46-specific oncolytic measles virus resistant to neutralization by measles-immune human serum.

The frequent overexpression of CD46 in malignant tumors has provided a basis to use vaccine-lineage measles virus (MeV) as an oncolytic virotherapy platform. However, widespread measles seropositivity limits the systemic deployment of oncolytic MeV for the treatment of metastatic neoplasia. Here, we...

Fuld beskrivelse

Bibliografiske detaljer

Principais autores:	Miguel Ángel Muñoz-Alía, Rebecca A Nace, Alexander Tischer, Lianwen Zhang, Eugene S Bah, Matthew Auton, Stephen J Russell
Format:	Artigo
Sprog:	Inglês
Udgivet:	Public Library of Science (PLoS) 2021-02-01
Serier:	PLoS Pathogens
Online adgang:	https://journals.plos.org/plospathogens/article/file?id=10.1371/journal.ppat.1009283&type=printable
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!